Head-to-Head Comparison of Novel Vaccine Technologies Comes with a Minefield of Challenges
Modern vaccine development is having a golden period, with a variety of novel subunit technologies being introduced into clinical development in recent years. This opens the opportunity to find the best platform to use for novel vaccine antigen candidates through head-to-head comparative studies. Se...
Main Author: | Dennis Christensen |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-12-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/16/1/12 |
Similar Items
-
Overcoming the Neonatal Limitations of Inducing Germinal Centers through Liposome-Based Adjuvants Including C-Type Lectin Agonists Trehalose Dibehenate or Curdlan
by: Maria Vono, et al.
Published: (2018-02-01) -
The adjuvants dmLT and mmCT enhance humoral immune responses to a pneumococcal conjugate vaccine after both parenteral or mucosal immunization of neonatal mice
by: Jenny Lorena Molina Estupiñan, et al.
Published: (2023-01-01) -
A comprehensive review of BBV152 vaccine development, effectiveness, safety, challenges, and prospects
by: Farokh Dotiwala, et al.
Published: (2022-09-01) -
An evaluation of cytokine and cellular immune responses to heterologous prime-boost vaccination with influenza A/H7N7-A/H7N9 inactivated vaccine
by: Hana M El Sahly, et al.
Published: (2020-12-01) -
Heterologous DNA Prime- Subunit Protein Boost with Chikungunya Virus E2 Induces Neutralizing Antibodies and Cellular-Mediated Immunity
by: Fernanda Caroline Coirada, et al.
Published: (2023-06-01)